enfortumab,cisplatin,pembrolizumab,carboplatin,gemcitabine
seagen,astellas,merck
['bladder', 'ev103']
excited to see the ev103 cohort a long term results from tomorrow #kidneybladderorals #asco23 
I treat & research GU cancers @UTSW Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Tweets=my opinions ASCO: https://t.co/Whk29PATXe